Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation

Hellenic Journal of Cardiology

Volumn 46, Issue 5, 2005, Pages 336-340

  Kochiadakis, George E ^a   Kanoupakis, Emmanuel M ^a   Igoumenidis, Nikolaos E ^a   Mavrakis, Hercules E ^a   Kafarakis, Panagiotis K ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Amiodarone; Atrial fibrillation; Rate control

Indexed keywords

ACENOCOUMAROL; AMIODARONE; DIGITALIS; PLACEBO;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIGITALIZATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; EXERCISE; FEMALE; GAS EXCHANGE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; DIGOXIN; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION;

EID: 29244449057     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Blitzer M, Costeas C, Kassotis J, Reiffel JA: Rhythm management in atrial fibrillation - with a primary emphasis on pharmacological therapy: Part 1. Pacing Clin Electrophysiol 1998; 21: 590-602.
2. Jung F, DiMarco JP: Treatment strategies for atrial fibrillation. Am J Med 1998; 104: 272-286.
3. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150.
4. Kochiadakis GE, Igoumenidis NE, Parthenakis FI, Chlouverakis GI, Vardas PE: Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1999; 33: 966-971.
5. Kochiadakis GE, Igoumenidis NE, Solomou MC, Kaleboubas MD, Chlouverakis GI, Vardas PE: Efficacy of amiodarone for the termination of persistent atrial fibrillation. Am J Cardiol 1999; 83: 58-61.
6. Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-2027.
7. Connolly SJ: Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-2034.
8. Bourke JP, Cowan JC, Tansuphaswadikul S, Campbell RW: Antiarrhythmic drug effects on left ventricular performance. Eur Heart J 1987; 8 Suppl A: 105-111.
9. Gill J, Heel RC, Fitton A: Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992; 43: 69-110.
10. Tse HF, Lam YM, Lau CP, Cheung BM, Kumana CR: Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation. Clin Exp Pharmacol Physiol 2001; 28: 446-450.
11. Vorperian VR, Havighurst TC, Miller S, January CT: Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30: 791-798.